Therefore, aim of this study was to investigate the relationship between hepatic and systemic DPP4 levels/activity and the presence of NAFLD/NASH in individuals with and without obesity and T2DM. This evidence concerns the gene DPP4 and metabolic dysfunction-associated steatotic liver disease.